7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-10-17 2007-09-30 2007-06-30 2007-03-31 2005-06-30 2005-03-31 2004-12-31 2004-09-30 2004-06-30 2004-03-31 2003-12-31 2003-03-31 2002-03-31 2001-03-31 
      
    		                                                                                     
      operating activities
    		                                                                                     
      net income
    		-135,400,000 79,900,000 52,300,000 82,600,000 72,700,000 62,900,000 14,600,000 53,400,000 5,700,000 12,100,000 -14,300,000 -40,200,000 41,500,000 13,400,000 10,300,000 12,400,000 15,600,000 6,800,000 26,100,000 258,200,000 21,800,000 21,000,000 8,500,000 12,500,000 18,700,000 14,600,000 1,000,000 47,900,000 22,700,000 13,100,000 6,300,000 27,014,000 2,106,000 3,332,000 -2,952,000 -3,878,000 13,684,000 19,563,000 -4,672,000 -231,144,000 4,271,000 17,082,000 5,275,000 27,210,000 23,152,000 20,371,000 12,339,000 25,804,000 24,847,000 20,603,000 16,108,000 21,151,000 18,885,000 18,136,000 14,152,000 8,583,000 17,238,000 11,020,000 7,403,000 9,963,000 6,665,000 2,458,000 1,419,000 15,571,000 8,228,000   21,674,000 20,402,000 22,192,000 14,656,000 16,418,000 12,112,000 8,448,000 7,178,000 8,536,000 5,535,000      -18,078,000 -3,453,000 405,000 
      less: income from discontinued operations, net of tax
    		0 0 -2,000,000 -700,000 -400,000 -200,000 -2,200,000                                                                               
      net income from continuing operations
    		-135,400,000 79,900,000 54,300,000  73,100,000 63,100,000 16,800,000                                                                               
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                                     
      depreciation and amortization
    		71,400,000 71,100,000 66,200,000 69,900,000 68,100,000 66,000,000 65,900,000 67,900,000 67,000,000 62,900,000 33,300,000 19,500,000 20,200,000 21,700,000 20,500,000 20,800,000 20,500,000 19,800,000 19,500,000 19,100,000 18,600,000 23,600,000 23,900,000 22,700,000 24,100,000 16,000,000 16,000,000 13,900,000 10,000,000 13,200,000 13,700,000 13,241,000 10,178,000 9,320,000 9,161,000 8,904,000 9,419,000 9,707,000 9,479,000 11,314,000 11,550,000 11,208,000 11,376,000 11,580,000 11,236,000 10,188,000 10,172,000 10,146,000 10,280,000 10,049,000 9,914,000 9,425,000 8,213,000 7,335,000 7,223,000 7,505,000 7,021,000 6,737,000 6,652,000 6,002,000 5,945,000 5,853,000 5,777,000 5,475,000 5,399,000 5,270,000 5,268,000 5,467,000 5,668,000 5,298,000 4,880,000 5,036,000 4,496,000 4,587,000 4,587,000 2,008,000 1,944,000 1,937,000 2,170,000 2,192,000 2,191,000 -5,382,000 2,607,000 2,770,000 4,871,000 
      employee share-based compensation expense
    		4,900,000 4,300,000 6,200,000 4,600,000 4,200,000 4,100,000 6,000,000 3,400,000 2,600,000 2,600,000 4,000,000 2,700,000 2,300,000 2,300,000 3,300,000 3,100,000 2,300,000 2,400,000 3,400,000 2,100,000 1,900,000 2,000,000 2,900,000 2,600,000 2,100,000 1,900,000 2,400,000 1,400,000 100,000 200,000 3,200,000 1,545,000 1,569,000 1,712,000 6,274,000 1,665,000 1,826,000 1,651,000 5,537,000 2,122,000 1,417,000 2,034,000 5,752,000 1,807,000 1,730,000 1,926,000 3,957,000 3,207,000 1,707,000 2,511,000 2,564,000 1,750,000                                  
      financing costs amortization
    		4,700,000 4,900,000 4,800,000 4,900,000 4,800,000 4,700,000 4,700,000 5,200,000 4,800,000 4,400,000 2,800,000 800,000 700,000 700,000 700,000 4,800,000 1,200,000 1,100,000 1,200,000 1,100,000 1,100,000 1,100,000 1,000,000    400,000 300,000 300,000 400,000 300,000 337,000 321,000 321,000 321,000 321,000 321,000 321,000 321,000 321,000 322,000 321,000 326,000 413,000 326,000 327,000 326,000 327,000 326,000 327,000 326,000 327,000 326,000 556,000 321,000  445,000 324,000 325,000  370,000 1,962,000 404,000  404,000 404,000 404,000  628,000 413,000 413,000  413,000 416,000 404,000        817,000 1,324,000  
      unrealized foreign currency transaction gain
    		7,100,000       -4,300,000 1,300,000 -2,500,000 1,700,000  100,000 -3,200,000 -1,100,000  -2,900,000 1,700,000 -4,600,000        -300,000        193,000 226,000 -31,000 399,000 -50,000            346,000                                   
      unrealized gain on investments in equity securities
    		              2,600,000                                                                       
      loss on sale of business
    		    0 0 7,800,000                                                                               
      other non-cash operating activities
    		4,000,000 1,800,000 -600,000 -11,200,000 2,000,000 -800,000 1,800,000 800,000 -6,300,000 1,300,000 100,000 7,900,000 2,300,000 -900,000 2,000,000 -7,300,000 800,000 -200,000 1,900,000 3,500,000 -4,400,000 -800,000 3,200,000    2,500,000 -3,800,000   300,000 1,325,000 1,243,000 -874,000 606,000 1,666,000 -1,444,000 548,000 506,000 873,000 288,000 -1,066,000 642,000 -103,000 294,000 -479,000 118,000 465,000 494,000 3,122,000 433,000 6,774,000 -1,346,000 494,000 243,000  -1,815,000 278,000 -291,000  225,000 -229,000 2,595,000  -19,000 -323,000 1,083,000  2,204,000 -1,474,000 -181,000  -100,000 619,000 -354,000 307,000 56,000  298,000 -17,000 -45,000  316,000 20,000  
      changes in assets and liabilities, net of acquisitions:
    		                                                                                     
      accounts receivable
    		41,100,000 -14,100,000 23,300,000 30,500,000 -45,200,000 51,200,000 -51,000,000 -14,600,000 1,000,000 -56,300,000 -6,600,000 900,000 -600,000 -28,400,000 -17,200,000 700,000 -12,500,000 -33,000,000 13,600,000 -36,800,000 8,600,000 10,600,000 7,500,000 22,000,000 12,700,000 1,100,000 -12,200,000 2,000,000 2,900,000 2,700,000 17,900,000 -26,789,000 -4,464,000 -22,025,000 16,178,000 -12,088,000 23,177,000 -11,597,000 44,126,000 -10,074,000 32,422,000 -8,278,000 -6,875,000 3,308,000 16,243,000 -21,015,000 44,543,000 -9,236,000 -39,294,000 -3,865,000 -16,892,000 31,839,000 -14,325,000 -19,483,000 5,391,000 -10,692,000 6,706,000 -26,461,000 -2,648,000 2,309,000 7,508,000 -15,052,000 2,621,000 -22,342,000 12,102,000 27,185,000 -1,728,000 88,000 616,000 -4,891,000 6,692,000 -17,478,000 14,901,000 -13,645,000 -2,800,000 -9,100,000 25,000 -2,873,000 5,844,000 -8,186,000 554,000 -5,513,000 1,390,000 5,334,000  
      inventories
    		-16,200,000 16,300,000 -8,900,000 30,500,000 19,400,000 9,100,000 -4,100,000 23,400,000 6,000,000 -19,000,000 10,400,000  -2,800,000 -20,600,000 -35,000,000  -30,400,000 -28,800,000 -36,300,000  2,600,000 -13,100,000 -16,100,000  -2,600,000                                                             
      unbilled contract revenue
    		-50,900,000 -112,500,000 -89,000,000 -72,000,000 -9,500,000                                                                                 
      prepaid expenses and other current assets
    		8,400,000 1,700,000 -16,600,000 20,800,000 26,600,000                                                                                 
      accounts payable and other current liabilities
    		-23,000,000 49,200,000 -62,900,000 80,500,000 67,200,000                                              -8,764,000 21,070,000 4,902,000 4,583,000 -27,619,000 10,379,000 20,241,000 -2,635,000 -10,096,000 5,108,000 7,742,000 1,246,000 -3,591,000 -9,578,000 2,663,000 -15,457,000 5,805,000 -1,854,000 379,000 -533,000 -10,979,000 24,992,000 1,583,000 -9,070,000 1,740,000 3,266,000 676,000 98,000 2,060,000 2,906,000 -462,000 -311,000 2,235,000 -8,882,000  
      customer advances and billings in excess of contract revenue
    		2,500,000 -200,000 -41,900,000 9,300,000 -19,300,000 -11,300,000 17,300,000 -69,700,000 -12,500,000 17,200,000 6,800,000 -31,200,000 -3,600,000 31,700,000 31,000,000 -14,500,000 34,200,000 19,300,000 -10,500,000 -6,700,000 -8,400,000 9,300,000 -3,500,000 7,300,000 -9,900,000 -2,000,000 -2,500,000 7,000,000 -10,900,000 -4,200,000 13,000,000 8,913,000 10,916,000 -7,857,000 4,428,000 3,369,000 -5,673,000 -4,651,000 12,066,000 1,863,000 -11,454,000 -5,711,000 5,592,000 -9,320,000 3,067,000 -19,287,000 7,127,000 -4,917,000 8,332,000 5,858,000 864,000 -17,893,000 -3,997,000 -2,523,000 5,462,000 26,390,000 11,407,000 20,405,000 -7,207,000 -1,796,000 703,000 2,224,000 -1,329,000 2,793,000 -14,981,000 -19,413,000 -14,397,000 -8,788,000 29,418,000 304,000 16,407,000 4,306,000 6,424,000 -4,071,000 7,214,000 1,632,000 328,000 1,506,000 -3,264,000 7,553,000 836,000  -1,292,000 -799,000  
      termination fee paid by baker hughes
    		                                                                                     
      long-term assets and liabilities
    		-60,900,000 39,000,000 5,100,000 50,800,000 12,700,000                                                                                 
      net cash from continuing operating activities
    		118,000,000 147,900,000 -60,000,000 281,500,000 200,700,000 116,100,000 -89,600,000                                                                               
      net cash from discontinued operating activities
    		0   -100,000 -100,000 0 -5,500,000                                                                               
      net cash from operating activities
    		118,000,000 145,900,000 -60,000,000 281,400,000 200,600,000 116,100,000 -95,100,000 130,300,000 -22,600,000 91,600,000 -32,100,000 30,500,000 37,800,000 34,700,000 -22,200,000 20,300,000 -13,300,000 -36,600,000 8,300,000 78,500,000 13,900,000 54,800,000 25,500,000 78,600,000 55,700,000 32,800,000 -33,200,000 55,400,000 16,900,000 23,700,000 23,000,000 29,463,000 20,424,000 -4,087,000 1,200,000 24,222,000 59,763,000 48,650,000 38,179,000 46,893,000 46,478,000 7,118,000 1,500,000 52,612,000 23,762,000 21,482,000 20,861,000 40,230,000 9,051,000 34,020,000 -23,638,000 73,168,000 19,398,000 4,247,000 -9,172,000 44,615,000 51,822,000 3,607,000 -18,386,000 1,489,000 22,405,000 4,885,000 9,795,000 10,344,000 17,695,000 32,526,000 26,361,000 10,979,000 59,609,000 13,197,000 14,027,000 28,349,000 45,782,000 7,339,000 1,037,000 3,102,000 -4,063,000 6,403,000 11,051,000 8,315,000 9,290,000 -14,478,000 6,984,000 267,000  
      investing activities
    		                                                                                     
      capital expenditures
    		-23,300,000 -23,900,000 -20,100,000 -20,500,000 -26,100,000 -28,100,000 -46,100,000 -17,600,000 -63,600,000 -23,000,000 -31,400,000 -26,000,000 -18,400,000 -17,200,000 -12,600,000 -16,200,000 -9,800,000 -15,200,000 -11,500,000 -11,000,000 -5,900,000 -10,700,000 -10,300,000 -9,500,000 -11,600,000 -9,200,000 -5,900,000 -9,200,000 -7,300,000 -12,500,000 -6,600,000 -11,793,000 -6,650,000 -8,371,000 -8,386,000 -4,374,000 -3,993,000 -4,186,000 -5,232,000 -10,973,000 -11,587,000 -9,651,000 -14,828,000 -19,249,000 -17,221,000 -15,248,000 -10,417,000 -21,776,000 -21,583,000 -17,148,000 -12,078,000 -14,734,000 -12,149,000 -10,457,000 -6,345,000 -7,219,000 -4,728,000 -6,167,000 -4,266,000 -5,154,000 -3,886,000 -3,960,000 -3,939,000 -3,786,000 -4,345,000 -2,735,000 -2,324,000 -4,679,000 -2,906,000 -2,682,000 -3,701,000 -3,453,000 -4,984,000 -5,567,000 -5,024,000 -2,898,000 -1,734,000 -3,862,000 -1,951,000 -2,475,000 -1,091,000 1,389,000 -550,000 -1,198,000  
      free cash flows
    		94,700,000 122,000,000 -80,100,000 260,900,000 174,500,000 88,000,000 -141,200,000 112,700,000 -86,200,000 68,600,000 -63,500,000 4,500,000 19,400,000 17,500,000 -34,800,000 4,100,000 -23,100,000 -51,800,000 -3,200,000 67,500,000 8,000,000 44,100,000 15,200,000 69,100,000 44,100,000 23,600,000 -39,100,000 46,200,000 9,600,000 11,200,000 16,400,000 17,670,000 13,774,000 -12,458,000 -7,186,000 19,848,000 55,770,000 44,464,000 32,947,000 35,920,000 34,891,000 -2,533,000 -13,328,000 33,363,000 6,541,000 6,234,000 10,444,000 18,454,000 -12,532,000 16,872,000 -35,716,000 58,434,000 7,249,000 -6,210,000 -15,517,000 37,396,000 47,094,000 -2,560,000 -22,652,000 -3,665,000 18,519,000 925,000 5,856,000 6,558,000 13,350,000 29,791,000 24,037,000 6,300,000 56,703,000 10,515,000 10,326,000 24,896,000 40,798,000 1,772,000 -3,987,000 204,000 -5,797,000 2,541,000 9,100,000 5,840,000 8,199,000 -13,089,000 6,434,000 -931,000  
      proceeds from sale of business
    		                                                                                     
      investments
    		0 0 -1,400,000 0 0 -7,100,000 -6,000,000 -2,800,000 -6,200,000 -500,000 -2,100,000 -5,000,000 -1,000,000 0 -3,900,000 -700,000 -50,300,000 -12,900,000 -40,000,000     0                                                              
      other investing activities
    		-2,500,000 0 400,000 -5,300,000 6,200,000 -5,200,000 -600,000                                             74,000    0 0 0 388,000 0   -2,344,000 -2,246,000            32,000 105,000 -884,000 302,000 513,000 74,000 -261,000 376,000 367,000 290,000 
      net cash from continuing investing activities
    		-25,800,000   -19,700,000 -26,000,000                                                                                 
      net cash from discontinued investing activities
    		   0 0                                                                                 
      net cash from investing activities
    		-25,800,000 -23,900,000 -21,100,000 -19,700,000 -26,000,000 -43,800,000 -51,800,000 164,800,000 242,900,000 -24,000,000 -4,373,800,000 -31,300,000 -14,600,000 -38,200,000 -17,500,000 -52,800,000 -174,100,000 -28,000,000 -106,300,000 204,000,000 1,200,000 -10,000,000 -10,200,000 -9,300,000 -613,900,000 -10,600,000 -8,900,000 -222,500,000 -7,200,000 -11,900,000 -19,000,000 -11,921,000 -429,176,000 -7,500,000 -31,403,000 -4,342,000 -3,550,000 -4,957,000 -5,232,000 -2,293,000 -35,589,000 -20,502,000 -15,140,000 -19,348,000 -17,220,000 -20,910,000 -15,007,000 -21,271,000 -21,452,000 -20,180,000 -12,078,000 -14,627,000 -192,918,000 -10,457,000 -6,345,000  -40,798,000 -7,777,000 -3,878,000  -8,339,000 -6,728,000 -6,283,000  -6,806,000 -7,982,000 -289,000 -36,943,000 -2,906,000 -21,510,000 -4,317,000 -1,354,000 -4,947,000 -5,594,000 -6,646,000 -13,171,000 -1,629,000 -455,000 -433,000 -1,412,000 -1,017,000 -14,947,000 51,000 -831,000  
      financing activities
    		                                                                                     
      borrowings on credit facilities
    		791,200,000 738,900,000 746,200,000 1,448,400,000 801,900,000 850,600,000 634,200,000 560,800,000 611,500,000                                                                             
      repayments on credit facilities
    		-743,800,000 -810,900,000 -666,600,000 -1,380,700,000 -910,200,000 -857,000,000 -479,300,000 -666,900,000 -849,500,000                                                                             
      repayments on term loan
    		       -150,100,000 -4,400,000           -335,700,000 -2,800,000 -2,800,000 -2,800,000     -2,900,000 0       -1,441,000 0                                                 
      payments for debt issuance costs
    		   -100,000 -4,800,000 -3,800,000 -1,500,000 -2,700,000 -100,000 -11,900,000 -121,500,000         0 900,000   0 -10,900,000   -1,200,000 0 0 -200,000                                                       
      common stock repurchases from share-based compensation plans
    		-600,000 -300,000 -3,900,000  -200,000 -100,000 -3,000,000 0 -300,000 -100,000 -2,600,000 -200,000 -100,000 -100,000 -3,200,000 -3,200,000 0 -200,000 -3,000,000 -200,000 0 0 -1,700,000                                                               
      dividend distribution to noncontrolling interests
    		0                                                                                     
      dividends paid on mandatory convertible preferred stock
    		-6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,800,000 -6,900,000                                                                           
      other financing activities
    		-1,100,000 1,900,000 -3,200,000                                     0 1,000 0 -157,000             -9,000 0 0 -1,090,000 2,000 0 -23,000 -33,000         -1,080,000 1,956,000 447,000 5,000 45,000 27,000 -217,000 -43,000    -41,000 -81,000  
      net cash from financing activities
    		-36,200,000 -83,400,000 65,700,000 -250,500,000 -120,100,000 -17,000,000 143,900,000 -265,500,000 -255,400,000 -34,400,000 1,967,800,000 2,513,600,000 -79,600,000 54,300,000 15,900,000 55,600,000 91,300,000 147,200,000 87,800,000 -264,600,000 -45,000,000 -11,800,000 -42,000,000 -35,600,000 496,300,000 53,500,000 -2,600,000 30,900,000 1,200,000 -3,900,000 10,000,000 -20,982,000 300,085,000 -690,000 -3,213,000 -1,109,000 -2,251,000 10,892,000 199,000 -451,000 -10,175,000   -69,798,000 -865,000 1,871,000 -2,001,000 -33,280,000 34,381,000 -15,713,000 22,719,000 -22,797,000 19,177,000 19,079,000 1,982,000 -162,131,000 222,660,000 7,659,000 -477,000 155,000   -33,000 -77,000 466,000   68,000 -6,301,000 827,000 1,345,000 2,626,000 5,727,000 19,000 -928,000 11,941,000 -624,000 -9,073,000 -13,951,000 -10,936,000 -1,784,000 1,931,000 -598,000 -4,279,000 5,521,000 
      effect of exchange rate changes on cash and cash equivalents
    		800,000 7,400,000 2,900,000 -13,200,000 7,400,000 -200,000 -2,600,000 6,600,000 -2,300,000 -300,000 2,200,000 3,000,000 -3,800,000 -1,000,000 1,300,000 -3,800,000 400,000   4,400,000 10,200,000 200,000 -3,000,000 4,600,000 -5,900,000 900,000 -1,500,000 -4,700,000 -2,900,000 -7,700,000 3,900,000                                                       
      net increase in cash, cash equivalents, restricted cash and restricted cash equivalents
    		56,800,000    61,900,000                                                                                 
      cash, cash equivalents, restricted cash, and restricted cash equivalents at beginning of period
    		0 0 310,500,000 0 0 0 201,100,000 0 0 0 2,605,300,000 0 0 0 122,400,000 0 0 0 126,100,000  0 0 120,000,000 0 0 0 119,100,000 0 0 0 131,400,000 -949,000 0 0 282,949,000                                                   
      cash, cash equivalents, restricted cash, and restricted cash equivalents at end of period
    		56,800,000 46,000,000 298,000,000 -2,000,000 61,900,000 55,100,000 195,500,000 41,200,000 -42,400,000 32,900,000 169,400,000 2,515,800,000 -60,200,000 49,800,000 99,900,000 19,300,000 -95,700,000 82,900,000 115,900,000  -1,800,000 33,200,000 90,300,000 38,300,000 -67,800,000 76,600,000 72,900,000 -39,100,000 8,700,000 200,000 149,300,000 -2,043,000 -107,423,000 -9,394,000 250,260,000                                                   
      net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents
    		  -12,500,000    -5,600,000                                                                               
      income from continuing operations
    		                       12,500,000 18,700,000 14,600,000 1,000,000 18,200,000                                                   6,924,000 4,223,000 4,034,000     
      bridge loan facility fees
    		       0 0 0 26,100,000                                                                           
      deferred income tax benefit
    		                                                                                     
      acquisition of business, net of cash acquired
    		                                                                   0 0                 
      proceeds from sale of businesses, net of cash divested
    		                                                                                     
      cash received from settlement of cross-currency swap agreement
    		                                                                                     
      borrowings on senior secured and senior unsecured notes
    		                                                                                     
      repayment of convertible notes
    		                                                                                     
      borrowings on term loan
    		       100,000 0 250,000,000 1,497,200,000             0            0 0                                                 
      proceeds from issuance of common stock
    		       0 0 0 11,700,000                                                                           
      proceeds from issuance of preferred stock
    		                                                                                     
      net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents
    		         32,900,000 -2,435,900,000     19,300,000 -95,700,000    -1,800,000   38,300,000 -67,800,000 76,600,000 -46,200,000 -39,100,000 8,700,000 200,000 17,900,000 -1,094,000 -107,423,000 -9,394,000 -32,689,000                                                   
      unrealized foreign currency transaction (gain) loss
    		      -13,500,000             5,400,000        -1,200,000 -200,000 -400,000 -400,000            -60,000     -3,337,000                                      
      unrealized (gain) loss on investments in equity securities
    		                  -3,300,000                                                                   
      equity in loss (income) of unconsolidated affiliates
    		    800,000                                                                                 
      acquisition of businesses, net of cash acquired
    		        17,500,000 0 -4,339,800,000 0 -500,000 -24,500,000 -800,000 -36,000,000 -114,100,000 0 -55,000,000     0 -599,700,000 -1,400,000 -2,800,000 -213,300,000 0 0 -12,500,000 -96,000 -422,842,000 0 -23,162,000 32,000 0   0    0 0   0    0    0 -36,070,000   -38,700,000 -4,053,000   -10,029,000 -2,810,000                     
      payment of contingent consideration
    		       0 -2,700,000                               0 0   0 0       0    0                              
      proceeds from exercise of stock options
    		    0 100,000 300,000 100,000 700,000 100,000 100,000 300,000 500,000 400,000 1,000,000 -100,000 400,000 1,000,000 5,600,000 6,800,000 1,600,000 600,000 2,000,000 0 200,000 900,000 8,300,000 5,400,000 3,600,000 600,000 1,200,000         0 17,000 47,000 422,000 57,000 82,000 108,000 516,000 50,000 823,000 549,000 3,913,000                                   
      net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents including cash classified within current assets held for sale
    		                                                                                     
      less: net increase in cash classified within current assets held for sale
    		                                                                                     
      unrealized loss on investments in equity securities
    		     300,000 1,700,000  5,200,000 4,600,000 2,000,000                                                                           
      equity in loss of unconsolidated affiliates
    		      300,000    500,000                                                                           
      unbilled contract revenues and other assets
    		      -133,800,000 -281,500,000 -35,100,000 -15,300,000 174,900,000  -10,100,000 -22,400,000 -36,100,000  -37,200,000 -29,700,000 -6,800,000 -4,800,000 -13,500,000 4,900,000 8,400,000 10,200,000 10,200,000 -10,800,000 -11,200,000 -19,300,000   6,400,000 15,031,000 -14,666,000 11,082,000 -4,847,000 -17,918,000 8,409,000 11,125,000 19,187,000 -920,000 -774,000 10,502,000 3,442,000 -11,166,000 -27,040,000 15,583,000 -28,844,000  12,884,000                                     
      accounts payable and other liabilities
    		      -9,500,000 485,300,000 -56,100,000 81,300,000 -273,800,000 332,600,000 -10,600,000 30,800,000 -3,500,000 -11,500,000 5,500,000 -8,500,000 4,100,000 78,400,000 6,200,000 -4,800,000 -17,000,000 -1,200,000 1,000,000 0 -20,700,000 15,500,000 -24,700,000 17,600,000 -18,600,000 3,324,000 11,763,000 -6,057,000 -10,530,000 32,315,000 -3,486,000 8,332,000 -48,239,000 19,560,000 -5,197,000 -22,648,000 -8,008,000 23,021,000 -8,511,000 17,542,000 -20,392,000 12,693,000 -16,773,000                                     
      proceeds from sale of assets
    		      900,000 5,000,000   100,000         0 7,100,000           -25,000 185,000       30,000 195,000 192,000 8,000 -99,000 1,000 1,657,000 34,000 505,000    33,000                          4,291,000 1,216,000    225,000   
      realized gain on equity method investment
    		           0 0                                                                         
      realized gain on investments in equity securities
    		                                                                                     
      equity in (earnings) loss of unconsolidated affiliates
    		       -300,000 -1,200,000                                                                             
      government grants and other
    		       -100,000 -300,000 -400,000 -600,000 -300,000 -500,000 -100,000 -200,000                                                                       
      payments for equity issuance costs
    		                       0 -600,000                                                             
      net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents
    		              -22,500,000    -10,200,000    -29,700,000                                                               
      gain on sale of business
    		                                                                                     
      dividend distribution to noncontrolling interest
    		        -3,800,000                    0               0 0   0 0                                     
      net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents including cash classified within current assets held for sale
    		                                                                                     
      borrowings on revolving credit facility
    		          634,800,000  70,000,000 179,300,000 254,000,000                                                                       
      repayments on revolving credit facility
    		          -45,000,000  -150,000,000 -125,300,000 -235,900,000                                                                       
      interest accretion of convertible notes discount
    		                   2,100,000 2,000,000 2,000,000 1,900,000 1,900,000 2,000,000 1,900,000 1,800,000 1,800,000 2,300,000 2,500,000 2,500,000 2,773,000 3,408,000 3,342,000 3,277,000 3,213,000 3,150,000 3,089,000 3,029,000 2,969,000 2,912,000 2,855,000 2,799,000 2,745,000 2,691,000 2,639,000 2,587,000 2,537,000 2,487,000 2,439,000 2,391,000 2,345,000 2,299,000 2,227,000 2,238,000 2,168,000                              
      unrealized gain on investment in equity securities
    		                   -16,300,000                                                                  
      realized gain on investment in equity securities
    		                                                                                     
      equity in loss (earnings) of unconsolidated affiliates
    		           200,000 -300,000 300,000 300,000                                                                       
      deferred income tax expense
    		                                                                                     
      asset impairments
    		                                                                                     
      gain on bargain purchase
    		                                                                                     
      inventory
    		                          -10,400,000 14,600,000 7,600,000 -14,700,000 -21,600,000 7,564,000 -1,907,000 3,552,000 -20,909,000 9,433,000 9,194,000 10,163,000 -3,111,000 20,061,000 9,729,000 959,000 -18,761,000 10,956,000 -2,282,000 -4,680,000 -12,144,000 -608,000 3,892,000 -259,000 -15,704,000 6,817,000 1,080,000 -6,600,000 -17,074,000 -9,435,000 -6,094,000 -3,188,000 -12,911,000 -4,665,000 -9,993,000 3,198,000 -2,257,000 7,598,000 6,201,000 9,645,000 1,777,000 8,877,000 1,081,000 -3,043,000 -15,211,000 -1,632,000 511,000 -3,189,000 -6,812,000 -2,656,000 -4,261,000         
      unbilled contract revenue and other assets
    		                                                                                     
      proceeds from sale of businesses
    		                                                                                     
      cash received from settlement of cross-currency swap agreements
    		           0                                                                          
      borrowings on revolving credit facilities
    		               717,000,000 220,000,000 236,400,000 187,700,000 120,500,000 1,000,000 29,000,000 64,500,000 33,200,000 150,600,000 33,200,000 18,800,000 223,400,000 123,300,000 27,000,000 38,000,000 24,000 300,000,000 0 2,176,000 0 0 0 3,820,000 0 56,450,000   80,935,000 0 4,601,000 3,283,000 41,073,000 73,319,000 51,253,000 48,978,000 54,625,000                        14,597,000 1,029,000 382,000 983,000   -16,208,000 8,008,000 17,602,000 28,396,000 
      repayments on revolving credit facilities
    		               -552,000,000 -129,100,000 -90,000,000 -102,500,000 -56,000,000 -45,700,000 -36,700,000 -84,700,000 -66,900,000 -92,900,000 -264,300,000 -27,000,000 -193,500,000 -68,500,000 -28,000,000 -26,800,000 -61,003,000 0 -1,470,000 -3,627,000 0 -2,245,000 -760,000 -3,056,000 0 -66,453,000   -83,910,000 0 0 -3,252,000 -74,621,000 -39,771,000 -65,273,000 -31,738,000                                -7,580,000 -17,287,000  
      common stock repurchases
    		                   0 0 0 -19,300,000 800,000 0 -100,000 -2,700,000 -300,000 -100,000 -100,000 -2,200,000 -46,000 -111,000 -49,000 -1,794,000 -46,000 -15,000 -42,000 -601,000 -99,000 -26,000 -15,000 -808,000 -41,000 -35,000 -117,000 -3,174,000 -23,000 -76,000 -24,000 -1,879,000 53,000 -46,000 -18,000 -4,473,000                               
      unrealized (gain) loss on investment in equity securities
    		                                                                                     
      realized gain on investment of equity securities
    		                                                                                     
      equity in earnings of unconsolidated affiliates
    		                                                                                     
      deferred income tax (benefit) expense
    		                                                                                     
      government grants
    		               100,000 100,000 100,000 200,000    100,000 200,000 700,000 0 -200,000 0 100,000 600,000 100,000 -7,000 131,000 131,000 145,000 0 443,000                                                 
      issuance of shares
    		                       0 0                                                             
      repurchase of convertible notes
    		                           0                                                          
      less: income from discontinued operations
    		                           29,700,000                                                          
      discontinued operations
    		                                                                                     
      cash from operating activities
    		                           -31,700,000                                                          
      cash from investing activities
    		                                                                                     
      cash from discontinued operations
    		                           101,800,000                                                          
      unrealized loss on investment in equity securities
    		                     -1,000,000 4,800,000                                                               
      loss on extinguishment of debt
    		                                                                                     
      proceeds from issuance of convertible notes
    		                                                       0                              
      proceeds from issuance of warrants
    		                                                       0                              
      payments for call options related to convertible notes
    		                                                                                     
      other operating activities
    		                        -2,600,000                                                             
      other
    		                                                                                     
      cash (used in) investing activities
    		                                                                                     
      unrealized foreign currency transaction loss
    		                               85,000 -43,000              1,072,000                                       
      payments for china land use rights
    		                                       0                                              
      excess tax benefit from share-based compensation
    		                                   50,000 0 30,000 24,000      26,000 163,000 1,564,000  1,023,000 89,000 4,383,000                                   
      proceeds from exercise of options
    		                                196,000 829,000 32,000  9,000 5,000 12,000              1,481,000 118,000 1,725,000      7,000                         
      excess tax benefits from share-based compensation
    		                                                                                     
      effect of exchange rate changes on cash
    		                                1,244,000 2,883,000 727,000  156,000 -481,000 2,200,000 -2,978,000 -1,062,000 1,859,000 -5,624,000 -232,000 -7,929,000 -188,000 -779,000 -162,000 4,066,000 1,387,000 -2,233,000 -21,000 5,409,000 -680,000 -806,000 -449,000 -4,014,000 1,890,000 4,625,000 -2,313,000 7,813,000 -5,443,000 -1,170,000 -2,541,000 2,771,000 3,099,000 -1,226,000 -823,000 -2,753,000 784,000 4,013,000  1,588,000 153,000 42,000 -189,000 204,000 247,000 -62,000 333,000 -302,000 -719,000 -48,000 -171,000 52,000 
      deferred income taxes
    		                                                                                     
      payments on long-term debt
    		                                                                                     
      net increase in cash and cash equivalents
    		                                   14,683,000 54,118,000 54,104,000 35,346,000 41,171,000 -348,000 -482,000 -20,289,000  -2,252,000 2,255,000 3,074,000 -14,483,000    35,723,000    -124,735,000   -22,741,000 -41,221,000 12,143,000 -19,344,000 3,479,000 24,542,000 11,355,000 24,931,000 26,072,000 -25,896,000 50,402,000 -7,486,000 11,055,000  46,562,000 1,764,000 -6,537,000 1,872,000 -6,316,000 -3,125,000 -3,333,000 -4,033,000 6,489,000 -29,086,000 6,437,000   
      cash and cash equivalents at beginning of period
    		                                   0 0 0 123,708,000 0 0 0 103,656,000 0 0 0 137,345,000 0 0 0 141,498,000 0 0 0 256,861,000 0 0 0 165,112,000 0 0 0 211,168,000 0 0 0 122,165,000 0 0 0 92,869,000  0 0 18,854,000 0 14,814,000 0 0 0 18,600,000 20,590,000 7,225,000 11,801,000 4,921,000 
      cash and cash equivalents at end of period
    		                                   14,683,000 54,118,000 54,104,000 159,054,000 41,171,000 -348,000 -482,000 83,367,000 -36,766,000 -2,252,000 2,255,000 140,419,000 -14,483,000 26,046,000 -486,000 126,268,000 35,723,000 -148,934,000 12,189,000 242,520,000 -125,184,000 229,670,000 5,379,000 146,996,000 -43,534,000 19,956,000 -24,787,000 213,477,000 22,001,000 14,126,000 28,030,000 147,011,000 -26,719,000 47,649,000 -6,702,000 107,937,000 30,443,000 48,150,000 1,917,000 12,359,000 1,683,000 8,702,000 -2,878,000 -3,395,000 -3,700,000 24,787,000 -9,215,000 13,614,000 6,787,000 3,268,000 
      asset impairment
    		                                        447,000                                             
      payments for land use rights
    		                                                                                     
      excess tax (deficiency) benefit from exercise of stock options
    		                                                                                     
      excess tax (deficiency) benefit from share-based compensation
    		                                        -44,000 -12,000 -482,000                                           
      changes in asset and liabilities, net of acquisitions:
    		                                                                                     
      acquisition of businesses
    		                                                                                     
      advance payment on acquisition
    		                                              -4,624,000                                       
      acquisition of business
    		                                          -320,000                                           
      net cash from by financing activities
    		                                          -1,025,000                                           
      impairment of intangible assets
    		                                                   0 0                                 
      reversal of contingent consideration liability
    		                                                   0 0                                 
      proceeds from long-term debt
    		                                                   0 0                                 
      excess tax benefit from exercise of stock options
    		                                                                                     
      net decrease in cash and cash equivalents
    		                                                 -486,000 -15,230,000   12,189,000 -14,341,000                             -4,843,000  
      principal payments on long-term debt
    		                                            -938,000 -937,000 -938,000 -937,000 -937,000 -938,000 -938,000 -938,000 -937,000 -938,000 -1,625,000 -1,625,000   -1,625,000 -1,625,000        0    0 0   -653,000 -651,000 -8,700,000 -13,241,000 -10,575,000 -632,000 -9,641,000 -171,000 -176,000  
      call premium related to redemption of long-term debt
    		                                                                                     
      loss on disposal of assets
    		                                                       -1,012,000                              
      unbilled contract revenues and other current assets
    		                                                  -15,224,000 -3,583,000 154,000 -2,374,000 -1,662,000 -705,000 -3,884,000 -6,105,000 -255,000 -8,143,000 1,474,000 858,000 3,257,000 15,809,000 -3,056,000 6,517,000 7,842,000 -2,085,000 -1,872,000 -6,283,000 -3,805,000 2,168,000 4,784,000 15,741,000 -10,481,000           
      payment of deferred financing costs
    		                                                   0 13,000    -6,993,000    -305,000                         
      retirement of long-term debt, including call premium
    		                                                                                     
      payment for call options related to convertible notes
    		                                                       0                              
      tax benefit from exercise of stock options
    		                                                   1,038,000 1,579,000 0 6,355,000 895,000 0       -85,000 11,000   68,000 213,000 515,000 639,000               
      gain on acquisition of business
    		                                                           0 0                         
      foreign currency losses
    		                                                    1,677,000                                 
      increase in cash resulting from changes in operating assets and liabilities, net of acquisitions:
    		                                                                                     
      employee stock and stock option related compensation expense
    		                                                     1,676,000 2,505,000 1,225,000 1,407,000 1,400,000 1,401,000 1,372,000 1,300,000 1,362,000 899,000 877,000 754,000 803,000 845,000 -320,000 1,085,000 1,214,000 1,155,000 507,000 658,000 7,503,000 361,000 779,000 592,000 634,000 749,000 582,000 468,000     
      increase in cash resulting from changes in operating assets and liabilities:
    		                                                                                     
      foreign currency gains
    		                                                      -352,000                               
      amortization of deferred financing costs
    		                                                                                     
      foreign currency transaction (gain) loss
    		                                                          -759,000                           
      changes in assets and liabilities:
    		                                                                                     
      proceeds from maturities of short term investments
    		                                                                                     
      net cash (used in) investing activities
    		                                                                                     
      payment of financing costs
    		                                                                          -183,000           
      stock option exercise proceeds
    		                                                         2,647,000 2,238,000            706,000               
      proceeds from issuance of short-term debt
    		                                                                                     
      foreign currency (gains) losses
    		                                                        -2,390,000                             
      asset impairment charge
    		                                                            609,000                         
      loss on disposal of equipment
    		                                                                                     
      principal payments on long term debt
    		                                                                                     
      deferred acquisition payment
    		                                                                                     
      reversal of contingent liability on insolvent subsidiary
    		                                                                                     
      foreign currency transaction gain
    		                                                                                     
      purchase of short term investments
    		                                                                                     
      foreign currency expense
    		                                                            -143,000                         
      proceeds from maturities of short-term investments
    		                                                                0 0 2,035,000                   
      net cash (used) provided by financing activities
    		                                                                                     
      payments on revolving credit facilities and short term debt
    		                                                                                     
      underwriters’ over-allotment proceeds
    		                                                                                     
      warrant and stock option exercise proceeds
    		                                                                                     
      acquisition of minority interest and other assets
    		                                                                      -616,000  37,000 -27,000 -1,622,000           
      proceeds from exercise of warrants and options
    		                                                                    311,000                 
      net income attributable to chart industries, inc.
    		                                                                  19,462,000                   
      loss on sale or disposal of assets
    		                                                                                     
      minority interest
    		                                                                                    21,000 
      short term investments
    		                                                                                     
      initial public offering proceeds
    		                                                                                     
      dividend payment
    		                                                                                     
      acquisition of other assets
    		                                                                    0                 
      net payments on revolving credit facilities or short-term debt
    		                                                                        0             
      proceeds from secondary stock offering
    		                                                                        231,000             
      contributions from joint venture partners
    		                                                                        0             
      payments on revolving credit facilities or short-term debt
    		                                                                          -750,000           
      inventory purchase accounting charge
    		                                                                                     
      gain on sale of assets
    		                                                                             -49,000 -282,000   4,696,000 -182,000   
      purchased in- process research and development charge.
    		                                                                                     
      foreign currency transaction gain.
    		                                                                                     
      changes in assets and liabilities, net of effects from acquisition:
    		                                                                                     
      payments to predecessor company shareholders for acquisition
    		                                                                                     
      proceeds from equity contribution
    		                                                                                     
      payment of exercised stock options
    		                                                                                     
      payment of acquisition costs
    		                                                                                     
      proceeds from sale of stock
    		                                                                             0 0 0 400,000     
      net increase in cash and cash equivalents.
    		                                                                                     
      effect of exchange rate changes on cash.
    		                                                                                     
      cash and cash equivalents at beginning of period.
    		                                                                                     
      cash and cash equivalents
    		                                                                                     
      prepaid expenses
    		                                                                                     
      other current assets
    		                                                                                     
      assets held for sale
    		                                                                                     
      total current assets
    		                                                                                     
      property, plant and equipment.
    		                                                                                     
      goodwill
    		                                                                                     
      identifiable intangible assets
    		                                                                                     
      other assets
    		                                                                                     
      total assets
    		                                                                                     
      accounts payable
    		                                                                                     
      accrued salaries, wages and benefits
    		                                                                                     
      warranty reserve
    		                                                                                     
      other current liabilities
    		                                                                                     
      short-term debt
    		                                                                                     
      total current liabilities
    		                                                                                     
      long-term debt
    		                                                                                     
      long-term deferred tax liability
    		                                                                                     
      other non-current liabilities
    		                                                                                     
      shareholder equity
    		                                                                                     
      total liabilities and shareholder equity
    		                                                                                     
      proceeds from initial public offering
    		                                                                                     
      cash dividend paid
    		                                                                                     
      reorganization value in excess of amounts allocable to identifiable assets
    		                                                                             153,000        
      employee separation and plant closure costs
    		                                                                            99,000 96,000     357,000 234,000  
      purchased in-process research and development charge
    		                                                                                     
      equity income from joint venture
    		                                                                                     
      payments on revolving credit facilities
    		                                                                           -2,048,000 -1,029,000 -382,000 -983,000       
      warrant and option exercise proceeds
    		                                                                                     
      debt restructuring-related fees paid
    		                                                                                     
      payments on interest rate collars
    		                                                                             -156,000    247,000    
      (gain) on settlement or sale of assets
    		                                                                                     
      proceeds from settlement or sale of assets
    		                                                                                     
      proceeds from initial public offering — net
    		                                                                                     
      (gain) loss on settlement sale of assets
    		                                                                                     
      debt restructuring related fees paid
    		                                                                              -18,000 -312,000 -1,552,000     
      unbilled contract revenue and other current assets
    		                                                                            -9,057,000         
      adjustments to reconcile net income from continuing operations to net cash from operating activities:
    		                                                                                     
      reorganization items
    		                                                                                     
      loss on insolvent subsidiary
    		                                                                                  13,682,000   
      debt restructuring-related fees expensed
    		                                                                                     
      goodwill impairment charge
    		                                                                                     
      equity loss (income) from joint venture
    		                                                                                     
      contribution of stock to employee benefit plans
    		                                                                                    684,000 
      inventory and other current assets
    		                                                                             -6,254,000 -2,721,000 -1,402,000 1,714,000 1,848,000 4,318,000 1,204,000  
      income tax refund
    		                                                                                     
      dividends received from joint venture
    		                                                                                     
      purchases of treasury stock
    		                                                                                     
      cash flow provided by continuing operations
    		                                                                             -3,125,000 -3,333,000 -4,033,000 6,489,000     
      cash flow provided by discontinued operation
    		                                                                                     
      adjustments to reconcile income from continuing operations to net cash from operating activities:
    		                                                                                     
      debt restructuring related fees expensed
    		                                                                                     
      equity loss in joint venture
    		                                                                                     
      cumulative effect of change in accounting principle
    		                                                                                    88,000 
      billings in excess of contract revenue and customer advances
    		                                                                                     
      cash flow provided by continuing operation
    		                                                                                     
      debt restructuring-related professional fees expensed
    		                                                                                     
      increase in cash resulting from changes in operating assets and liabilities, excluding effect of discontinued operation:
    		                                                                                     
      financing activities**
    		                                                                                     
      cash flows from continuing operations
    		                                                                                     
      cash flows from discontinued operation
    		                                                                                     
      financing costs expensed
    		                                                                                  814,000   
      financing costs paid
    		                                                                                  -814,000   
      amendment-related fees expensed
    		                                                                                     
      amendment-related professional fees expensed
    		                                                                                   2,515,000  
      amendment-related fees paid
    		                                                                                   -4,337,000  
      adjustments to reconcile net income
    		                                                                                     
      provided by operating activities:
    		                                                                                     
      income from joint venture
    		                                                                                     
      treasury stock and stock option transactions
    		                                                                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.